GBIO — Generation Bio Co Income Statement
0.000.00%
Last trade - 00:00
- $192.78m
- -$71.58m
- $5.90m
- 14
- 17
- 68
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 5.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 62.3 | 81.1 | 119 | 141 | 144 |
Operating Profit | -62.3 | -81.1 | -119 | -141 | -139 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -61.3 | -80.5 | -119 | -137 | -127 |
Net Income After Taxes | -61.3 | -80.5 | -119 | -137 | -127 |
Net Income Before Extraordinary Items | |||||
Net Income | -61.3 | -80.5 | -119 | -137 | -127 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -61.3 | -80.5 | -119 | -137 | -127 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.06 | -1.74 | -2.12 | -2.25 | -1.96 |
Dividends per Share |